The health system has been decimated. Although violence has fallen, emergency funding is still well short of needs. Sharmila ...

Available disease-modifying therapies can prevent relapses and relapse-associated worsening in people with multiple sclerosis by targeting autoimmunity through various mechanisms. However, these ...

Motor neuron diseases are a group of progressive and ultimately fatal neurodegenerative disorders of the motor system, ...

Truelove and Witts published the first placebo-controlled, randomised clinical trial in inflammatory bowel disease (IBD), which showed the superiority of cortisone for the treatment of acute ...

In The Lancet Infectious Diseases, Fernando Abad-Franch and colleagues1 present the results of a study that used distributions in case data to assess the effect of mosquito-disseminated pyriproxyfen ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar ...

Copyright: © 2024 Published by Elsevier Ltd. For a city that's famous for the number and steepness of its hills, Edinburgh ...

Copyright: © 2024 Published by Elsevier Ltd. As the global population ages, Alzheimer's disease and other forms of dementia ...

The incidence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis increases with age.1 Despite this trend, ...

Susac syndrome is a rare inflammatory vascular endotheliopathy affecting the small vessels of the brain, eye, and ear.1,2 ...

Despite enormous effort, disease-modifying therapies for Alzheimer's disease, the most common cause of dementia, have proven ...

Despite the availability of evidence-based treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), their use frequently results in incomplete recovery.1 Intravenous ...